Most Read Articles
Roshini Claire Anthony, 5 days ago

Individuals with moderate-to-severe plaque psoriasis may reap better long-term improvements in the severity of their condition when treated with guselkumab over secukinumab, according to findings of the phase III ECLIPSE* trial presented at the recent Inflammatory Skin Disease Summit (ISDS 2018) held in Vienna, Austria.

Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
Elvira Manzano, 6 days ago
Treatment with two investigational, oral JAK inhibitors may be beneficial in individuals with moderate‐to‐severe alopecia areata (spot baldness), an autoimmune disease that can cause a lot of anxiety, according to an ongoing phase II study.
4 days ago
Discontinuing the use of tyrosine kinase inhibitors (TKIs) in the treatment of patients with chronic myeloid leukaemia appears to be feasible in real-life clinical practice in the context of close molecular monitoring, a study reports.

Eczema severity linked to mental health problems in schoolchildren

28 Oct 2018

Schoolchildren with severe eczema are at heightened risk of mental health problems including emotional symptoms, conduct problems, hyperactivity/inattention and peer problems, a study has found. 

Researchers looked at 9,954 schoolchildren in the 2nd to the 8th grades from the ToMMo Child Health Study, a cross-sectional survey in Miyagi Prefecture, Japan.

Eczema status was evaluated according to the International Study of Asthma and Allergies in Childhood (ISAAC) Eczema Symptom Questionnaire. Mental health problems were identified using the clinical ranges of Strengths and Difficulties Questionnaire (SDQ) total difficulties scores and the four SDQ subcategories of emotional symptoms, conduct problems, hyperactivity/inattention, and peer problems.

Mean SDQ total difficulties scores significantly increased with worsening eczema status (p≤0.004 for trend). The odds ratios for SDQ total difficulties were 1.51 (95 percent CI, 1.31–1.74) for mild/moderate eczema and 2.63 (1.91–3.63) for severe eczema (p<0.001 for trend) vs normal eczema.

Similar results were obtained for the four SDQ subcategories. Specifically, greater eczema severity was associated with increased emotional symptoms, conduct problems, hyperactivity/inattention and peer problems (p≤0.017 for all).

In light of the finding that the presence of eczema in schoolchildren is associated with multiple psychiatric symptoms, researchers advised that physicians treating this population pay attention to potential mental health problems.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 5 days ago

Individuals with moderate-to-severe plaque psoriasis may reap better long-term improvements in the severity of their condition when treated with guselkumab over secukinumab, according to findings of the phase III ECLIPSE* trial presented at the recent Inflammatory Skin Disease Summit (ISDS 2018) held in Vienna, Austria.

Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
Elvira Manzano, 6 days ago
Treatment with two investigational, oral JAK inhibitors may be beneficial in individuals with moderate‐to‐severe alopecia areata (spot baldness), an autoimmune disease that can cause a lot of anxiety, according to an ongoing phase II study.
4 days ago
Discontinuing the use of tyrosine kinase inhibitors (TKIs) in the treatment of patients with chronic myeloid leukaemia appears to be feasible in real-life clinical practice in the context of close molecular monitoring, a study reports.